“IS IT POSSIBLE TO PREDICT TUMOR PROGRESSION THROUGH GENOMIC CHARACTERIZATION OF MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA? MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA”, Mediterr J Hematol Infect Dis, vol. 16, no. 1, p. e2024044, Apr. 2024, doi: 10.4084/MJHID.2024.044.